In conclusion, the present data, together with those previously published on patients with primary Sjӧgren syndrome [39], suggest that CD4+CD25low/-GITR+ cells are expanded pTregs in response to an effector/Treg imbalance and are able to control, at least in part, the disease. The gene discussed is CD4; the disease is Sjogren syndrome.